BCLS II Equity Opportunities GP, LLC — SEC Form 4 filings

SEC reporting owner CIK 2008174. 1 Form 4 filing on record with FilingPulse; latest filed 2025-02-21.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2025-02-21 to 2025-02-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Solid Biosciences Inc. (SLDB)10% owner11 leg · 1,000,000 sh · $4,030,0001

Form 4 filings — BCLS II Equity Opportunities GP, LLC

FiledFormIssuerReported transactionsSource
2025-02-214Solid Biosciences Inc. (SLDB)
jointly with Bain Capital Life Sciences Investors, LLC, BCLS SB Investco, LP, Bain Capital Life Sciences Partners, LP, Bain Capital Life Sciences Fund II, L.P., Bain Capital Life Sciences Investors II, LLC, BCLS II Investco, LP, BCLS II Investco (GP), LLC, BCIP Life Sciences Associates, LP, BCLS II Equity Opportunities, LP
Purchase (P): 1,000,000 @ $4.03 · Purchase (P): 6,444,170 (derivative) @ $4.03EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2008174 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →